The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Revolution Medicines Inc shares valued at $206,484 were sold by Cislini Jeff on Dec 16 ’25. At $76.82 per share, Cislini Jeff sold 2,688 shares. The insider’s holdings dropped to 47,884 shares worth approximately $3.64 million following the completion of this transaction.
Also, GOLDSMITH MARK A sold 15,394 shares, netting a total of over 1,182,526 in proceeds. Following the sale of shares at $76.82 each, the insider now holds 232,469 shares.
Before that, Kelsey Stephen Michael had sold 5,447 shares from its account. In a trade valued at $418,423, the insider traded Revolution Medicines Inc shares for $76.82 each. Upon closing the transaction, the insider’s holdings decreased to 5,447 shares, worth approximately $21.16 million.
As published in their initiating research note from Wolfe Research on November 18, 2025, Revolution Medicines Inc [RVMD] has been an Outperform and the price target has been revised to $75. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early November. As of October 21, 2025, Mizuho has initiated its “an Outperform” rating for RVMD.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] plunged -1.02% to $75.96. The stock’s lowest price that day was $74.2, but it reached a high of $77.62 in the same session. During the last five days, there has been a drop of approximately -3.25%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 69.89%. Shares of the company reached a 52-week high of $81.49 on 12/08/25 and a 52-week low of $29.17 on 04/07/25.
Support And Resistance Levels for Revolution Medicines Inc (RVMD)
According to the 24-hour chart, there is a support level at 74.20, which, if violated, would cause prices to drop to 72.45. In the upper region, resistance lies at 77.71. The next price resistance is at 79.46. RSI (Relative Strength Index) is 59.62 on the 14-day chart, showing neutral technical sentiment.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp steep in short interest on 2025-11-28 dropping by -1.23 million shares to 16.79 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 18.02 million shares. A decline of -7.32% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.09 of the overall float, the days-to-cover ratio (short ratio) decline to 7.09.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 78.5 in the next 12 months, up nearly 2.29% from the previous closing price of $76.74. Analysts anticipate Revolution Medicines Inc stock to reach 99 by 2025, with the lowest price target being 75. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2025. On September 12, 2025, Raymond James assigned a price target of “a Strong buy” to the stock and resumed coverage with a $72.
